[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557355":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":33,"slug":7,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":36,"acronym":7,"eligibilityCriteria":37,"healthyVolunteers":34,"sex":38,"minAge":39,"maxAge":7,"enrollmentInfo":40,"targetDuration":7,"studyType":43,"phases":7,"briefSummary":44,"conditions":45,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":56},{"fullName":5,"class":6},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Lian Yang","CONTACT","18986273791","yanglian@hust.edu.cn",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Union Hospital，Tongji Medical College，Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","430000","China","CN",{"type":24,"coordinates":25},"Point",[26,27],114.26667,30.58333,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100557355",false,"NCT06537037","Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）","Inclusion Criteria:\n\n1. Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;\n2. Aged \\> 18 years old;\n3. At least one CT scan or MRI scan before treatment;\n4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.\n\nExclusion criteria：\n\n1. Poor image quality;\n2. Incomplete clinical data or loss of follow-up;\n3. Presence of another primary malignancy other than urologic cancer;\n4. Unclear pathological diagnosis。","ALL","18 Years",{"count":41,"type":42},150,"ESTIMATED","OBSERVATIONAL","This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.",[46],"Urologic Cancer","2024-07-31",{"date":49,"type":50},"2024-08-05","ACTUAL",{"date":52,"type":42},"2024-08",{"date":54,"type":42},"2027-08",{"name":5,"class":6},1]